141 related articles for article (PubMed ID: 33548921)
41. Evaluation of outcomes after stereotactic radiosurgery for pilocytic astrocytoma.
Trifiletti DM; Peach MS; Xu Z; Kersh R; Showalter TN; Sheehan JP
J Neurooncol; 2017 Sep; 134(2):297-302. PubMed ID: 28567590
[TBL] [Abstract][Full Text] [Related]
42. Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).
Müller K; Gnekow A; Falkenstein F; Scheiderbauer J; Zwiener I; Pietsch T; Warmuth-Metz M; Voges J; Nikkhah G; Flentje M; Combs SE; Vordermark D; Kocher M; Kortmann RD
Strahlenther Onkol; 2013 Aug; 189(8):647-55. PubMed ID: 23831852
[TBL] [Abstract][Full Text] [Related]
43. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
Radiother Oncol; 1999 Apr; 51(1):27-33. PubMed ID: 10386714
[TBL] [Abstract][Full Text] [Related]
44. Combination of Bronchial Arterial Infusion Chemotherapy plus Drug-Eluting Embolic Transarterial Chemoembolization for Treatment of Advanced Lung Cancer-A Retrospective Analysis of 23 Patients.
Zeng Y; Yin M; Zhao Y; Liu Y; Li X; Qi Y; Ma Y; Li Z; Li C; Wu G
J Vasc Interv Radiol; 2020 Oct; 31(10):1645-1653. PubMed ID: 32951974
[TBL] [Abstract][Full Text] [Related]
45. Treatment of childhood astrocytomas with irinotecan and cisplatin.
Mora J; Perez-Jaume S; Cruz O
Clin Transl Oncol; 2018 Apr; 20(4):500-507. PubMed ID: 28828715
[TBL] [Abstract][Full Text] [Related]
46. Dabrafenib in BRAFV600E mutant pilocytic astrocytoma in a pediatric patient.
Mustansir F; Mushtaq N; Darbar A
Childs Nerv Syst; 2020 Jan; 36(1):203-207. PubMed ID: 31418082
[TBL] [Abstract][Full Text] [Related]
47. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
48. Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.
Xi G; Li YD; Grahovac G; Rajaram V; Wadhwani N; Pundy T; Mania-Farnell B; James CD; Tomita T
Mol Cancer; 2017 Jan; 16(1):21. PubMed ID: 28137267
[TBL] [Abstract][Full Text] [Related]
49. Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?
Zhou X; Niu X; Liu P; Ou D; Zhu Y; Wang X
Front Immunol; 2021; 12():762663. PubMed ID: 34777379
[TBL] [Abstract][Full Text] [Related]
50. Treatment of recurrent brain tumors with intra-arterial cis-platinum and BCNU.
Kapp JP; Vance R
J Miss State Med Assoc; 1984 Jan; 25(1):1-6. PubMed ID: 6325705
[No Abstract] [Full Text] [Related]
51. Chemotherapy response criteria in malignant glioma.
Grant R; Liang BC; Slattery J; Greenberg HS; Junck L
Neurology; 1997 May; 48(5):1336-40. PubMed ID: 9153469
[TBL] [Abstract][Full Text] [Related]
52. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
53. Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions.
Nishio S; Morioka T; Takeshita I; Shono T; Inamura T; Fujiwara S; Fukui M
Clin Neurol Neurosurg; 1995 Nov; 97(4):300-6. PubMed ID: 8599896
[TBL] [Abstract][Full Text] [Related]
54. Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.
Liu SL; Sun XS; Yan JJ; Chen QY; Lin HX; Wen YF; Guo SS; Liu LT; Xie HJ; Tang QN; Liang YJ; Li XY; Lin C; Du YY; Yang ZC; Xiao BB; Yang JH; Tang LQ; Guo L; Mai HQ
Radiother Oncol; 2019 Aug; 137():83-94. PubMed ID: 31078941
[TBL] [Abstract][Full Text] [Related]
55. The role of stereotactic radiosurgery for low-grade astrocytomas.
Hadjipanayis CG; Kondziolka D; Flickinger JC; Lunsford LD
Neurosurg Focus; 2003 May; 14(5):e15. PubMed ID: 15669811
[TBL] [Abstract][Full Text] [Related]
56. Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas.
Komotar RJ; Burger PC; Carson BS; Brem H; Olivi A; Goldthwaite PT; Tihan T
Neurosurgery; 2004 Jan; 54(1):72-9; discussion 79-80. PubMed ID: 14683543
[TBL] [Abstract][Full Text] [Related]
57. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
58. Response of pediatric low grade gliomas to chemotherapy.
Gajjar A; Heideman RL; Kovnar EH; Langston JA; Sanford RA; Douglass EC; Jenkins JJ; Horowitz ME; Kun LE
Pediatr Neurosurg; 1993; 19(3):113-8; discussion 119-20. PubMed ID: 8499323
[TBL] [Abstract][Full Text] [Related]
59. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children.
Kato T; Sawamura Y; Tada M; Ikeda J; Ishii N; Abe H
J Neurooncol; 1998 May; 37(3):263-70. PubMed ID: 9524084
[TBL] [Abstract][Full Text] [Related]
60. Intra-arterial cisplatin for the treatment of malignant gliomas.
Newton HB; Page MA; Junck L; Greenberg HS
J Neurooncol; 1989 May; 7(1):39-45. PubMed ID: 2547032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
